The effect of smoking cessation on airway inflammation in young asthma patients
- PMID:24286379
- DOI: 10.1111/cea.12243
The effect of smoking cessation on airway inflammation in young asthma patients
Abstract
Background: Smoking has been shown to have several detrimental effects on asthma, including poor symptom control, attenuated treatment response and accelerated decline in lung function. In spite of this, smoking is at least as common among asthma patients as in the rest of the population. The aggravations of smoking on asthma may be caused by effects on airway inflammation, which has been found to be changed in asthmatic smokers. It is not known whether these smoking-induced airway inflammation changes are reversible after smoking cessation.
Objective: The aim of this study was to assess airway changes in asthmatic smokers before and during smoking cessation.
Methods: Forty-six smokers with asthma, all steroid-free (age range: 19-40), were recruited. All participants attempted smoking cessation over a period of 3 months. Visits were performed at weeks 0, 6 and 12 and included induced sputum, FeNO, methacholine challenge, lung function, Asthma Control Questionnaire (ACQ6) and exhaled CO.
Results: Twenty-six of 46 patients succeeded in quitting smoking. In the quitters, improvements in methacholine AHR (77% before and 52% after smoking cessation, respectively, P = 0.016) and ACQ6 score (1.7-0.7, P = 0.034) and FeNO (8.7-14.8 p.p.b., P = 0.002) were observed, whereas no significant changes were found regarding eosinophils or lung function. A small but significant decrease in neutrophils (54.1-52%, P = 0.003) was present in quitters compared with the non-quitters. Non-quitters experienced no changes in any parameters.
Conclusion: Smoking cessation improved asthma control, but the changes were not related to change in eosinophilic inflammation, and the reduction in neutrophils was small. Thus, airway inflammation with eosinophils and neutrophils may be less important drivers of asthma control in smokers than other factors.
Clinical relevance: Smoking cessation may improve clinically important disease parameters such as AHR and symptom score, but likely unrelated to changes in airway inflammation.
Keywords: airway hyperresponsiveness; airway inflammation; asthma; smoking cessation.
© 2013 John Wiley & Sons Ltd.
Similar articles
- Predictors of neutrophilic airway inflammation in young smokers with asthma.Westergaard CG, Munck C, Helby J, Porsbjerg C, Hansen LH, Backer V.Westergaard CG, et al.J Asthma. 2014 May;51(4):341-7. doi: 10.3109/02770903.2014.880718. Epub 2014 Jan 29.J Asthma. 2014.PMID:24404796
- Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD.Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Timens W, Postma DS.Willemse BW, et al.Eur Respir J. 2004 Sep;24(3):391-6. doi: 10.1183/09031936.04.00117603.Eur Respir J. 2004.PMID:15358697
- [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].Pan Y, Huang KW, Ye Q, Liu XS, Wu BM, Zhang J, Chang XH, Lu Y, Wang C.Pan Y, et al.Zhonghua Jie He He Hu Xi Za Zhi. 2009 Sep;32(9):679-84.Zhonghua Jie He He Hu Xi Za Zhi. 2009.PMID:20079282Chinese.
- The role of neutrophils in inflammation.Cox G.Cox G.Can Respir J. 1998 Jul-Aug;5 Suppl A:37A-40A.Can Respir J. 1998.PMID:9753515Review.
- Therapeutic implications of 'neutrophilic asthma'.Nair P, Aziz-Ur-Rehman A, Radford K.Nair P, et al.Curr Opin Pulm Med. 2015 Jan;21(1):33-8. doi: 10.1097/MCP.0000000000000120.Curr Opin Pulm Med. 2015.PMID:25415406Review.
Cited by
- Active and passive smoking impacts on asthma with quantitative and temporal relations: A Korean Community Health Survey.Kim SY, Sim S, Choi HG.Kim SY, et al.Sci Rep. 2018 Jun 5;8(1):8614. doi: 10.1038/s41598-018-26895-3.Sci Rep. 2018.PMID:29872096Free PMC article.
- The Link between Periodontal Disease and Asthma: How Do These Two Diseases Affect Each Other?Tamiya H, Abe M, Nagase T, Mitani A.Tamiya H, et al.J Clin Med. 2023 Oct 25;12(21):6747. doi: 10.3390/jcm12216747.J Clin Med. 2023.PMID:37959214Free PMC article.Review.
- Challenges and perspectives of tobacco cessation in special groups of patients and populations.Tsikrika S, Dai S, Dilektasli A, Katsaounou P, Dagli E.Tsikrika S, et al.Breathe (Sheff). 2023 Jun;19(2):220224. doi: 10.1183/20734735.0224-2022. Epub 2023 Aug 15.Breathe (Sheff). 2023.PMID:37645019Free PMC article.Review.
- Nicotine receptor partial agonists for smoking cessation.Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T.Cahill K, et al.Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.Cochrane Database Syst Rev. 2016.Update in:Cochrane Database Syst Rev. 2023 May 5;5:CD006103. doi: 10.1002/14651858.CD006103.pub8.PMID:27158893Free PMC article.Updated.Review.
- Nicotine receptor partial agonists for smoking cessation.Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N.Livingstone-Banks J, et al.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.Cochrane Database Syst Rev. 2023.PMID:37142273Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical